HMG-CoA reductase inhibitors inhibit pan-cancer epithelial-mesenchymal transition by targeting XBP1+ mast cells
收藏官方服务：
资源简介：
Aberrant activation of MEK/ERK signaling in XBP1+ mast cells can stimulate tumor cell EMT by modulating degranulation, while Simvastatin can inhibit EMT occurrence by suppressing degranulation.
提供机构：
Lisheng Peng创建时间：
2024-06-21
